Moreover, launches and approvals of various new hip implants are also expected to drive the market growth in near future. For instance, in October 2017, DePuy Synthes announced the first polymethylmethacrylate (PMMA) cement along with the TFNA system which is used to provide improved implant fixation of the hip in cases where potential risk of cut out is significant. Furthermore, in 2018, DePuy Synthes acquired Medical Enterprises Distribution LLC including the orthopedics assets of ME1000, a surgical impactor used in total hip replacement surgery.
On the basis of region, the global hip implant market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global hip implant market owing to launch and approvals of new hip replacement implants. For instance, in March 2018, the United Orthopedic Corporation, a designer, manufacturer and distributor of orthopedic implants and instruments, announced the launch of UTS (United Tri-tapered Short Stem) hip stem at the American Academy of Orthopedic Surgeons Annual Meeting in New Orleans, U.S. The UTS hip stem is designed for easier insertion through small incisions and it facilitates less invasive surgeries.
Europe is also expected to witness significant growth in the hip implants market due to high prevalence of hip fractures. For instance, according to the National Hip Fracture Database Annual Report 2018, nearly 76,000 cases of hip fractures are reported each year in the U.K.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients